{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:19:14Z","timestamp":1794503954831,"version":"4.9.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-64914-w","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T17:47:19Z","timestamp":1763056039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Human intestinal fungus Clavispora lusitaniae attenuates colitis through Pyruvate decarboxylase-derived Indole-3-ethanol"],"prefix":"10.1038","volume":"16","author":[{"given":"Fan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenpeng","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1753-5602","authenticated-orcid":false,"given":"Zhichao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1071-8510","authenticated-orcid":false,"given":"Shenghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqiao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhuo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangge","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4056-7987","authenticated-orcid":false,"given":"Xiaokui","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6251-7908","authenticated-orcid":false,"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4397-537X","authenticated-orcid":false,"given":"Xiaochi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"64914_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","volume":"574","author":"B Aykut","year":"2019","unstructured":"Aykut, B. et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature 574, 264\u2013267 (2019).","journal-title":"Nature"},{"key":"64914_CR2","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1136\/gutjnl-2021-325413","volume":"71","author":"X Huo","year":"2022","unstructured":"Huo, X. et al. Cultivated human intestinal fungus Candida metapsilosis M2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists. Gut 71, 2205\u20132217 (2022).","journal-title":"Gut"},{"key":"64914_CR3","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1136\/gutjnl-2022-327756","volume":"72","author":"H Sun","year":"2023","unstructured":"Sun, H. et al. Gut commensal Parabacteroides distasonis alleviates inflammatory arthritis. Gut 72, 1664\u20131677 (2023).","journal-title":"Gut"},{"key":"64914_CR4","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.chom.2024.04.017","volume":"32","author":"X Wang","year":"2024","unstructured":"Wang, X. et al. Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2\u03b1 signaling. Cell Host Microbe 32, 964\u2013979 (2024).","journal-title":"Cell Host Microbe"},{"key":"64914_CR5","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1016\/j.cell.2024.04.043","volume":"187","author":"Q Yan","year":"2024","unstructured":"Yan, Q. et al. A genomic compendium of cultivated human gut fungi characterizes the gut mycobiome and its relevance to common diseases. Cell 187, 2969\u20132989 (2024).","journal-title":"Cell"},{"key":"64914_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.cgh.2024.06.036","volume":"23","author":"C Ma","year":"2025","unstructured":"Ma, C., Solitano, V., Danese, S. & Jairath, V. The future of clinical trials in inflammatory bowel disease. Clin. Gastroenterol. Hepatol. 23, 480\u2013489 (2025).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"64914_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-065186","volume":"13","author":"R Wang","year":"2023","unstructured":"Wang, R., Li, Z., Liu, S. & Zhang, D. Global, regional and national burden of inflammatory bowel disease in 204 countries and territories from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019. Bmj. Open. 13, e065186 (2023).","journal-title":"Bmj. Open."},{"key":"64914_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"GG Kaplan","year":"2021","unstructured":"Kaplan, G. G. & Windsor, J. W. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 18, 56\u201366 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"64914_CR9","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/s41575-024-00989-y","volume":"21","author":"C Ma","year":"2024","unstructured":"Ma, C. et al. Interpreting modern randomized controlled trials of medical therapy in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 21, 792\u2013808 (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"64914_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00060-22","volume":"37","author":"A Yadegar","year":"2024","unstructured":"Yadegar, A. et al. Fecal microbiota transplantation: current challenges and future landscapes. Clin. Microbiol. Rev. 37, e0006022 (2024).","journal-title":"Clin. Microbiol. Rev."},{"key":"64914_CR11","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S2468-1253(23)00441-7","volume":"9","author":"L Bethlehem","year":"2024","unstructured":"Bethlehem, L. et al. Microbiota therapeutics for inflammatory bowel disease: the way forward. Lancet Gastroenterol. Hepatol. 9, 476\u2013486 (2024).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"64914_CR12","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1053\/j.gastro.2006.10.001","volume":"131","author":"G Dalmasso","year":"2006","unstructured":"Dalmasso, G. et al. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes. Gastroenterology 131, 1812\u20131825 (2006).","journal-title":"Gastroenterology"},{"key":"64914_CR13","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2017","unstructured":"Sokol, H. et al. Fungal microbiota dysbiosis in IBD. Gut 66, 1039\u20131048 (2017).","journal-title":"Gut"},{"key":"64914_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrgastro.2014.188","volume":"12","author":"PK Mukherjee","year":"2015","unstructured":"Mukherjee, P. K. et al. Mycobiota in gastrointestinal diseases. Nat. Rev. Gastroenterol. Hepatol. 12, 77\u201387 (2015).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"64914_CR15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.chom.2019.01.007","volume":"25","author":"JJ Limon","year":"2019","unstructured":"Limon, J. J. et al. Malassezia is associated with Crohn\u2019s sisease and exacerbates colitis in mouse models. Cell Host Microbe 25, 377\u2013388 (2019).","journal-title":"Cell Host Microbe"},{"key":"64914_CR16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41586-022-04502-w","volume":"603","author":"XV Li","year":"2022","unstructured":"Li, X. V. et al. Immune regulation by fungal strain diversity in inflammatory bowel disease. Nature 603, 672\u2013678 (2022).","journal-title":"Nature"},{"key":"64914_CR17","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.immuni.2019.05.023","volume":"50","author":"XV Li","year":"2019","unstructured":"Li, X. V., Leonardi, I. & Iliev, I. D. Gut mycobiota in immunity and inflammatory disease. Immunity 50, 1365\u20131379 (2019).","journal-title":"Immunity"},{"key":"64914_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix050","volume":"6","author":"Q He","year":"2017","unstructured":"He, Q. et al. Two distinct metacommunities characterize the gut microbiota in Crohn\u2019s disease patients. Gigascience 6, 1\u201311 (2017).","journal-title":"Gigascience"},{"key":"64914_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/1751-2980.12795","volume":"20","author":"YJ Weng","year":"2019","unstructured":"Weng, Y. J. et al. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease. J. Dig. Dis. 20, 447\u2013459 (2019).","journal-title":"J. Dig. Dis."},{"key":"64914_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle, A. & Sokol, H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 17, 223\u2013237 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"64914_CR21","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1136\/gutjnl-2011-301785","volume":"62","author":"MA Sedhom","year":"2013","unstructured":"Sedhom, M. A. et al. Neutralisation of the interleukin-33\/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut 62, 1714\u20131723 (2013).","journal-title":"Gut"},{"key":"64914_CR22","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1172\/JCI72189","volume":"124","author":"S D\u2019Alessio","year":"2014","unstructured":"D\u2019Alessio, S. et al. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. J. Clin. Invest. 124, 3863\u20133878 (2014).","journal-title":"J. Clin. Invest."},{"key":"64914_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1053\/j.gastro.2008.09.064","volume":"136","author":"F Scaldaferri","year":"2009","unstructured":"Scaldaferri, F. et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology 136, 585\u2013595 (2009).","journal-title":"Gastroenterology"},{"key":"64914_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20054-x","volume":"11","author":"O Levi-Galibov","year":"2020","unstructured":"Levi-Galibov, O. et al. Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer. Nat. Commun. 11, 6245 (2020).","journal-title":"Nat. Commun."},{"key":"64914_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd1453","volume":"7","author":"C Trilleaud","year":"2021","unstructured":"Trilleaud, C. et al. Agonist anti-ChemR23 mAb reduces tissue neutrophil accumulation and triggers chronic inflammation resolution. Sci. Adv. 7, eabd1453 (2021).","journal-title":"Sci. Adv."},{"key":"64914_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.pharmthera.2017.03.007","volume":"178","author":"F Li","year":"2017","unstructured":"Li, F., Zhu, W. & Gonzalez, F. J. Potential role of CYP1B1 in the development and treatment of metabolic diseases. Pharmacol. Ther. 178, 18\u201330 (2017).","journal-title":"Pharmacol. Ther."},{"key":"64914_CR27","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/bmj.284.6321.1014-a","volume":"284","author":"FM Stevens","year":"1982","unstructured":"Stevens, F. M. & Shaw, C. Prolactin-like immunoreactivity in human small-intestinal mucosa. Br. Med. J. 284, 1014\u20131015 (1982).","journal-title":"Br. Med. J."},{"key":"64914_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1172\/JCI38012","volume":"120","author":"J Huang","year":"2010","unstructured":"Huang, J. et al. Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling. J. Clin. Invest. 120, 223\u2013241 (2010).","journal-title":"J. Clin. Invest."},{"key":"64914_CR29","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1007\/s00535-024-02152-5","volume":"59","author":"Z Xiong","year":"2024","unstructured":"Xiong, Z. et al. Small extracellular vesicles derived from adipose mesenchymal stem cells alleviate intestinal fibrosis by inhibiting the FAK\/Akt signaling pathway via MFGE8. J. Gastroenterol. 59, 1092\u20131106 (2024).","journal-title":"J. Gastroenterol."},{"key":"64914_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adj5640","volume":"10","author":"Y Zhu","year":"2024","unstructured":"Zhu, Y. et al. The multilevel extensive diversity across the cynomolgus macaque captured by ultra-deep adaptive immune receptor repertoire sequencing. Sci. Adv. 10, eadj5640 (2024).","journal-title":"Sci. Adv."},{"key":"64914_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/gut.43.3.365","volume":"43","author":"A Stadnicki","year":"1998","unstructured":"Stadnicki, A. et al. Kallikrein-kininogen system activation and bradykinin (B2) receptors in indomethacin induced enterocolitis in genetically susceptible Lewis rats. Gut 43, 365\u2013374 (1998).","journal-title":"Gut"},{"key":"64914_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/1541-7786.MCR-05-0101","volume":"4","author":"TM Sissung","year":"2006","unstructured":"Sissung, T. M., Price, D. K., Sparreboom, A. & Figg, W. D. Pharmacogenetics and regulation of human cytochrome P450 1B1: implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention. Mol. Cancer Res. 4, 135\u2013150 (2006).","journal-title":"Mol. Cancer Res."},{"key":"64914_CR33","doi-asserted-by":"publisher","first-page":"18504","DOI":"10.1074\/jbc.RA119.009282","volume":"294","author":"H Dou","year":"2019","unstructured":"Dou, H. et al. Aryl hydrocarbon receptor (AhR) regulates adipocyte differentiation by assembling CRL4B ubiquitin ligase to target PPAR\u03b3 for proteasomal degradation. J. Biol. Chem. 294, 18504\u201318515 (2019).","journal-title":"J. Biol. Chem."},{"key":"64914_CR34","doi-asserted-by":"publisher","first-page":"4755","DOI":"10.1073\/pnas.1722124115","volume":"115","author":"J Fu","year":"2018","unstructured":"Fu, J. et al. Shared epitope-aryl hydrocarbon receptor crosstalk underlies the mechanism of gene-environment interaction in autoimmune arthritis. Proc. Natl. Acad. Sci. USA 115, 4755\u20134760 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64914_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33858-w","volume":"13","author":"S Dai","year":"2022","unstructured":"Dai, S. et al. Structural insight into the ligand binding mechanism of aryl hydrocarbon receptor. Nat. Commun. 13, 6234 (2022).","journal-title":"Nat. Commun."},{"key":"64914_CR36","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.ijbiomac.2022.04.048","volume":"209","author":"Y Song","year":"2022","unstructured":"Song, Y. et al. Molecular and structural basis of interactions of vitamin D3 hydroxyderivatives with aryl hydrocarbon receptor (AhR): An integrated experimental and computational study. Int. J. Biol. Macromol. 209, 1111\u20131123 (2022).","journal-title":"Int. J. Biol. Macromol."},{"key":"64914_CR37","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s12275-022-2059-2","volume":"60","author":"X Gong","year":"2022","unstructured":"Gong, X. et al. Effects of tryptophan and phenylalanine on tryptophol production in Saccharomyces cerevisiae revealed by transcriptomic and metabolomic analyses. J. Microbiol. 60, 832\u2013842 (2022).","journal-title":"J. Microbiol."},{"key":"64914_CR38","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2939","volume":"32","author":"HB Nielsen","year":"2014","unstructured":"Nielsen, H. B. et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat. Biotechnol. 32, 822\u2013828 (2014).","journal-title":"Nat. Biotechnol."},{"key":"64914_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41564-017-0089-z","volume":"3","author":"M Schirmer","year":"2018","unstructured":"Schirmer, M. et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat. Microbiol. 3, 337\u2013346 (2018).","journal-title":"Nat. Microbiol."},{"key":"64914_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.40","volume":"1","author":"S Jiang","year":"2022","unstructured":"Jiang, S. et al. Establishing a novel inflammatory bowel disease prediction model based on gene markers identified from single nucleotide variants of the intestinal microbiota. Imeta 1, e40 (2022).","journal-title":"Imeta"},{"key":"64914_CR41","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1016\/j.funbio.2024.05.013","volume":"128","author":"OC Rojas","year":"2024","unstructured":"Rojas, O. C., Montoya, A. M. & Trevi\u00f1o-Rangel, R. J. Clavispora lusitaniae: From a saprophytic yeast to an emergent pathogen. Fungal Biol. 128, 1933\u20131938 (2024).","journal-title":"Fungal Biol."},{"key":"64914_CR42","doi-asserted-by":"publisher","first-page":"110094","DOI":"10.1016\/j.enzmictec.2022.110094","volume":"160","author":"A Ochoa-Chac\u00f3n","year":"2022","unstructured":"Ochoa-Chac\u00f3n, A. et al. Fermentation performance of a Mexican native Clavispora lusitaniae strain for xylitol and ethanol production from xylose, glucose and cellobiose. Enzym. Microb. Technol. 160, 110094 (2022).","journal-title":"Enzym. Microb. Technol."},{"key":"64914_CR43","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3390\/microorganisms12050882","volume":"12","author":"Y Zhao","year":"2024","unstructured":"Zhao, Y. et al. Advancements in fermented beverage safety: Isolation and application of Clavispora iusitaniae Cl-p for ethyl carbamate degradation and enhanced flavor profile. Microorganisms 12, 882 (2024).","journal-title":"Microorganisms"},{"key":"64914_CR44","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.3390\/microorganisms8101477","volume":"8","author":"MA D\u00edaz","year":"2020","unstructured":"D\u00edaz, M. A. et al. Protection of citrus fruits from postharvest infection with Penicillium digitatum and degradation of patulin by biocontrol yeast Clavispora lusitaniae 146. Microorganisms 8, 1477 (2020).","journal-title":"Microorganisms"},{"key":"64914_CR45","doi-asserted-by":"publisher","first-page":"130154","DOI":"10.1016\/j.bbagen.2022.130154","volume":"1866","author":"AK Estrada-\u00c1vila","year":"2022","unstructured":"Estrada-\u00c1vila, A. K., Gonz\u00e1lez-Hern\u00e1ndez, J. C., Calahorra, M., S\u00e1nchez, N. S. & Pe\u00f1a, A. Xylose and yeasts: A story beyond xylitol production. Biochim. Biophys. Acta Gen. Subj. 1866, 130154 (2022).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"64914_CR46","doi-asserted-by":"publisher","first-page":"663744","DOI":"10.3389\/fmicb.2021.663744","volume":"12","author":"G Fan","year":"2021","unstructured":"Fan, G. et al. Isolation and identification of a high-yield ethyl caproate-producing yeast from Daqu and optimization of its fermentation. Front. Microbiol. 12, 663744 (2021).","journal-title":"Front. Microbiol."},{"key":"64914_CR47","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3390\/foods11101436","volume":"11","author":"Y Meng","year":"2022","unstructured":"Meng, Y. et al. Saccharomyces cerevisiae I4 Showed Alleviating Effects on Dextran Sulfate Sodium-Induced Colitis of Balb\/c Mice. Foods 11, 1436 (2022).","journal-title":"Foods"},{"key":"64914_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-immunol-070119-115104","volume":"38","author":"H Kayama","year":"2020","unstructured":"Kayama, H., Okumura, R. & Takeda, K. Interaction between the microbiota, epithelia, and immune cells in the intestine. Annu. Rev. Immunol. 38, 23\u201348 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"64914_CR49","first-page":"308","volume":"9","author":"AC Gomes","year":"2018","unstructured":"Gomes, A. C., Hoffmann, C. & Mota, J. F. The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes 9, 308\u2013325 (2018).","journal-title":"Gut Microbes"},{"key":"64914_CR50","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41575-021-00430-8","volume":"18","author":"B Stockinger","year":"2021","unstructured":"Stockinger, B., Shah, K. & Wincent, E. AHR in the intestinal microenvironment: safeguarding barrier function. Nat. Rev. Gastroenterol. Hepatol. 18, 559\u2013570 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"64914_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.immuni.2018.07.010","volume":"49","author":"A Metidji","year":"2018","unstructured":"Metidji, A. et al. The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity. Immunity 49, 353\u2013362 (2018).","journal-title":"Immunity"},{"key":"64914_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07859-7","volume":"10","author":"R Singh","year":"2019","unstructured":"Singh, R. et al. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat. Commun. 10, 89 (2019).","journal-title":"Nat. Commun."},{"key":"64914_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29098-7","volume":"13","author":"K Shah","year":"2022","unstructured":"Shah, K. et al. Cell-intrinsic Aryl Hydrocarbon receptor signalling is required for the resolution of injury-induced colonic stem cells. Nat. Commun. 13, 1827 (2022).","journal-title":"Nat. Commun."},{"key":"64914_CR54","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-019-0899-7","volume":"566","author":"K Gronke","year":"2019","unstructured":"Gronke, K. et al. Interleukin-22 protects intestinal stem cells against genotoxic stress. Nature 566, 249\u2013253 (2019).","journal-title":"Nature"},{"key":"64914_CR55","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/gutjnl-2022-327337","volume":"72","author":"C Michaudel","year":"2023","unstructured":"Michaudel, C. et al. Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases. Gut 72, 1296\u20131307 (2023).","journal-title":"Gut"},{"key":"64914_CR56","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2347722","volume":"16","author":"LW Xie","year":"2024","unstructured":"Xie, L. W. et al. Microbiota-derived I3A protects the intestine against radiation injury by activating AhR\/IL-10\/Wnt signaling and enhancing the abundance of probiotics. Gut Microbes 16, 2347722 (2024).","journal-title":"Gut Microbes"},{"key":"64914_CR57","doi-asserted-by":"publisher","first-page":"19376","DOI":"10.1073\/pnas.2000047117","volume":"117","author":"SA Scott","year":"2020","unstructured":"Scott, S. A., Fu, J. & Chang, P. V. Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. USA 117, 19376\u201319387 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64914_CR58","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nm.4102","volume":"22","author":"B Lamas","year":"2016","unstructured":"Lamas, B. et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat. Med. 22, 598\u2013605 (2016).","journal-title":"Nat. Med."},{"key":"64914_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01750-y","volume":"12","author":"G Wang","year":"2024","unstructured":"Wang, G. et al. Microbiota-derived indoles alleviate intestinal inflammation and modulate microbiome by microbial cross-feeding. Microbiome 12, 59 (2024).","journal-title":"Microbiome"},{"key":"64914_CR60","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.2022997","volume":"14","author":"M Meynier","year":"2022","unstructured":"Meynier, M. et al. AhR\/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms. Gut Microbes 14, 2022997 (2022).","journal-title":"Gut Microbes"},{"key":"64914_CR61","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D. & Patterson, A. D. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat. Rev. Microbiol. 21, 236\u2013247 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"64914_CR62","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41586-019-1865-0","volume":"577","author":"X Song","year":"2020","unstructured":"Song, X. et al. Microbial bile acid metabolites modulate gut ROR\u03b3(+) regulatory T cell homeostasis. Nature 577, 410\u2013415 (2020).","journal-title":"Nature"},{"key":"64914_CR63","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","volume":"24","author":"L Sun","year":"2018","unstructured":"Sun, L. et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat. Med. 24, 1919\u20131929 (2018).","journal-title":"Nat. Med."},{"key":"64914_CR64","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.chom.2024.04.020","volume":"32","author":"C Li","year":"2024","unstructured":"Li, C. et al. Enterococcus-derived tyramine hijacks \u03b1(2A)-adrenergic receptor in intestinal stem cells to exacerbate colitis. Cell Host Microbe 32, 950\u2013963 (2024).","journal-title":"Cell Host Microbe"},{"key":"64914_CR65","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu, W. et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell 165, 111\u2013124 (2016).","journal-title":"Cell"},{"key":"64914_CR66","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","volume":"24","author":"AB Roberts","year":"2018","unstructured":"Roberts, A. B. et al. Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential. Nat. Med. 24, 1407\u20131417 (2018).","journal-title":"Nat. Med."},{"key":"64914_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2021.152110","volume":"226","author":"AZ Banday","year":"2021","unstructured":"Banday, A. Z. et al. False-positive HIV serology, Candida lusitaniae pneumonia, and a novel mutation in the CYBB gene. Immunobiology 226, 152110 (2021).","journal-title":"Immunobiology"},{"key":"64914_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008921","volume":"16","author":"H Du","year":"2020","unstructured":"Du, H. et al. Candida auris: Epidemiology, biology, antifungal resistance, and virulence. PLoS Pathog. 16, e1008921 (2020).","journal-title":"PLoS Pathog."},{"key":"64914_CR69","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/19490976.2017.1290756","volume":"8","author":"HD Holscher","year":"2017","unstructured":"Holscher, H. D. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8, 172\u2013184 (2017).","journal-title":"Gut Microbes"},{"key":"64914_CR70","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nrendo.2016.142","volume":"13","author":"J Martel","year":"2017","unstructured":"Martel, J. et al. Anti-obesogenic and antidiabetic effects of plants and mushrooms. Nat. Rev. Endocrinol. 13, 149\u2013160 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"64914_CR71","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.3390\/polym15102373","volume":"15","author":"EJ Murphy","year":"2023","unstructured":"Murphy, E. J. et al. Polysaccharides-Naturally Occurring Immune Modulators. Polymers 15, 2373 (2023).","journal-title":"Polymers"},{"key":"64914_CR72","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ejmech.2018.01.030","volume":"145","author":"YZ Wu","year":"2018","unstructured":"Wu, Y. Z. et al. Bysspectin A, an unusual octaketide dimer and the precursor derivatives from the endophytic fungus Byssochlamys spectabilis IMM0002 and their biological activities. Eur. J. Med. Chem. 145, 717\u2013725 (2018).","journal-title":"Eur. J. Med. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64914-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64914-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64914-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T18:03:06Z","timestamp":1763056986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64914-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64914"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64914-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9980"}}